Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study

Katherine Majerovich, Mats Junek, Nader Khalidi and Stephanie Garner
The Journal of Rheumatology January 2023, jrheum.220860; DOI: https://doi.org/10.3899/jrheum.220860
Katherine Majerovich
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katherine Majerovich
Mats Junek
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mats Junek
Nader Khalidi
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nader Khalidi
Stephanie Garner
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Giant cell arteritis (GCA) is the most common large-vessel vasculitis that primarily affects older individuals.1 Prompt diagnosis and treatment with empiric glucocorticoids (GCs) is important because GCA can lead to ischemic complications, including visual loss.1,2

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
Katherine Majerovich, Mats Junek, Nader Khalidi, Stephanie Garner
The Journal of Rheumatology Jan 2023, jrheum.220860; DOI: 10.3899/jrheum.220860

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
Katherine Majerovich, Mats Junek, Nader Khalidi, Stephanie Garner
The Journal of Rheumatology Jan 2023, jrheum.220860; DOI: 10.3899/jrheum.220860
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Does the BNT162b2 Vaccine Trigger Antimelanoma Differentiation-Associated Gene 5 Antibody–Positive Interstitial Lung Disease?
  • Desk Rejections: Not Without Due Deliberation
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire